Get the Stockscreener App
0.5261
2.83%
0.0145
After Hours:
.51
-0.0161
-3.06%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Prophase Labs Inc stock is traded at $0.5261, with a volume of 821.45K.
It is up +2.83% in the last 24 hours and up +7.35% over the past month.
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
See More
Previous Close:
$0.5116
Open:
$0.5194
24h Volume:
821.45K
Relative Volume:
0.13
Market Cap:
$21.85M
Revenue:
$62.71M
Net Income/Loss:
$-10.48M
P/E Ratio:
-0.8351
EPS:
-0.63
Net Cash Flow:
$-13.77M
1W Performance:
-5.99%
1M Performance:
+7.35%
6M Performance:
+96.67%
1Y Performance:
-76.41%
1-Day Range:
$0.5051
$0.5618
1-Week Range:
$0.4783
$0.6659
52-Week Range:
$0.2179
$2.4999
Prophase Labs Inc Stock (PRPH) Company Profile
Name
Prophase Labs Inc
Sector
Industry
Phone
(215) 345-0919
Address
711 STEWART AVE, SUITE 200, NEW YORK, PA
Compare PRPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.5261 | 21.25M | 62.71M | -10.48M | -13.77M | -0.63 |
|
TMO
Thermo Fisher Scientific Inc
|
524.80 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
202.46 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
136.62 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
198.17 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-13-21 | Downgrade | Dawson James | Buy → Neutral |
| Jan-20-21 | Initiated | Dawson James | Buy |
Prophase Labs Inc Stock (PRPH) Latest News
Published on: 2025-10-10 04:36:34 - newser.com
Is ProPhase Labs Inc. meeting your algorithmic filter criteriaMarket Performance Summary & Safe Entry Trade Signal Reports - newser.com
Quantitative breakdown of ProPhase Labs Inc. recent moveWeekly Gains Report & Accurate Entry/Exit Alerts - newser.com
What technical models suggest about ProPhase Labs Inc.’s comeback2025 Investor Takeaways & Safe Capital Growth Stock Tips - newser.com
ProPhase Labs Inc. stock outlook for YEARTrade Risk Assessment & Expert Curated Trade Setups - newser.com
Can ProPhase Labs Inc. rally from current levelsPortfolio Gains Report & Proven Capital Preservation Methods - newser.com
Risk adjusted return profile for ProPhase Labs Inc. analyzedWeekly Trend Summary & Fast Moving Trade Plans - newser.com
Tick level data insight on ProPhase Labs Inc. volatilityMarket Performance Recap & Long-Term Safe Return Strategies - newser.com
What analyst consensus says on ProPhase Labs Inc. stock2025 Market Overview & Community Consensus Stock Picks - newser.com
Published on: 2025-09-29 08:39:17 - newser.com
ProPhase Labs’ COVID-19 testing subsidiaries file for bankruptcy - Investing.com India
Critical Biotech giant files Chapter 11 for 3 COVID labs, eyes Bitcoin treasury as lifeline - TheStreet
ProPhase Labs’ COVID-19 testing subsidiaries file for bankruptcy By Investing.com - Investing.com Canada
ProPhase Labs (PRPH) Files for Chapter 11 Bankruptcy for COVID-1 - GuruFocus
PROPHASE LABS, INC. ANNOUNCES COMPLETION OF IMPORTANT NEXT - GlobeNewswire
$50M Insurance Recovery Target: ProPhase Labs Strategic Bankruptcy Filing Could Net Multiple Returns - Stock Titan
ProPhase Labs explores crypto treasury strategy after shareholder vote By Investing.com - Investing.com Nigeria
ProPhase Continues its Exploration of a Crypto Treasury Strategy - GlobeNewswire
ProPhase Filed for Chapter 11 as $13M Liabilities Collide With Crypto Ambitions - USA Herald
ProPhase Labs explores crypto treasury strategy after shareholder vote - Investing.com India
ProPhase Units Hit Ch. 11 With Plans For Crypto Treasury - Law360
ProPhase Labs (PRPH) Embarks on Strategic Crypto Treasury Plan - GuruFocus
ProPhase Labs explores crypto treasury strategy after shareholder approval By Investing.com - Investing.com South Africa
ProPhase Labs explores crypto treasury strategy after shareholder approval - Investing.com
$50M Medical Collections Expected: ProPhase Labs Advances Crypto Strategy While Developing Cancer Test - Stock Titan
ProPhase Labs Partners with ThinkEquity for $6M Placement - MSN
Aug PostEarnings: Whats next for ProPhase Labs Inc stockJuly 2025 Retail & Risk Adjusted Buy and Sell Alerts - خودرو بانک
Volume Report: How correlated is ProPhase Labs Inc to the S P500Trade Risk Assessment & Weekly High Return Forecasts - khodrobank.com
Retail Trends: Whats the fair value of ProPhase Labs Inc stockProfit Target & Expert Approved Momentum Trade Ideas - خودرو بانک
Portfolio Update: Is ProPhase Labs Inc in a long term uptrend2025 Technical Patterns & Expert Verified Movement Alerts - خودرو بانک
Take Profit: Is ProPhase Labs Inc in a long term uptrendQuarterly Performance Summary & Real-Time Market Sentiment Reports - خودرو بانک
Prophase Labs Inc Stock (PRPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.17%
2.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):